scholarly article | Q13442814 |
P356 | DOI | 10.1111/JNC.14249 |
P698 | PubMed publication ID | 29105065 |
P50 | author | Christopher J.H. Porter | Q62833120 |
Philip Marriott | Q37830307 | ||
Martin J. Scanlon | Q43296605 | ||
Yijun Pan | Q57002116 | ||
Joseph A Nicolazzo | Q58243272 | ||
Kwok H C Choy | Q58243282 | ||
P2093 | author name string | Jennifer L Short | |
Siew Y Chai | |||
P2860 | cites work | Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARγ-mediated mechanisms in Alzheimer's disease models | Q21135583 |
Molecular recognition of fatty acids by peroxisome proliferator-activated receptors | Q22009367 | ||
A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease | Q24531755 | ||
Omega-3 Fatty Acids in Early Prevention of Inflammatory Neurodegenerative Disease: A Focus on Alzheimer's Disease | Q28080464 | ||
Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid | Q28115048 | ||
Heart type fatty acid binding protein (H-FABP) is decreased in brains of patients with Down syndrome and Alzheimer's disease | Q33201118 | ||
Hepatic steatosis in n-3 fatty acid depleted mice: focus on metabolic alterations related to tissue fatty acid composition | Q33388523 | ||
Fatty acid-binding protein 5 (FABP5) regulates cognitive function both by decreasing anandamide levels and by activating the nuclear receptor peroxisome proliferator-activated receptor β/δ (PPARβ/δ) in the brain | Q33556230 | ||
Capillary depletion method for quantification of blood-brain barrier transport of circulating peptides and plasma proteins | Q34035426 | ||
High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease. | Q34919010 | ||
Validation of a 2-day water maze protocol in mice | Q34999858 | ||
Comprehensive profiling of plasma fatty acid concentrations in young healthy Canadian adults | Q35078129 | ||
Alpha Adrenergic Induction of Transport of Lysosomal Enzyme across the Blood-Brain Barrier | Q35834506 | ||
The novel object recognition memory: neurobiology, test procedure, and its modifications | Q35904451 | ||
Pathophysiology of Alzheimer's disease. | Q36380458 | ||
Cognitive enhancement with rosiglitazone links the hippocampal PPARγ and ERK MAPK signaling pathways. | Q36616121 | ||
Graded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorder | Q36869854 | ||
Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver | Q37301574 | ||
Regulation of brain polyunsaturated fatty acid uptake and turnover | Q37304445 | ||
Omega-3 polyunsaturated fatty acids in Alzheimer's disease: key questions and partial answers. | Q37878521 | ||
The blood-brain barrier fatty acid transport protein 1 (FATP1/SLC27A1) supplies docosahexaenoic acid to the brain, and insulin facilitates transport | Q38723657 | ||
Association of Serum Docosahexaenoic Acid With Cerebral Amyloidosis | Q39482501 | ||
Impact and Therapeutic Potential of PPARs in Alzheimer's Disease | Q40576825 | ||
Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease | Q41159549 | ||
Plasma non-esterified docosahexaenoic acid is the major pool supplying the brain. | Q41817485 | ||
Fatty Acid Binding Protein 5 Modulates Docosahexaenoic Acid-Induced Recovery in Rats Undergoing Spinal Cord Injury. | Q41964462 | ||
Phosphatidylserine-dependent neuroprotective signaling promoted by docosahexaenoic acid | Q42215577 | ||
Effects of triglycerides, obesity, and starvation on ghrelin transport across the blood-brain barrier | Q42695713 | ||
Effects of the endogenous PPAR-alpha agonist, oleoylethanolamide on MDMA-induced cognitive deficits in mice | Q43211015 | ||
Altered brain uptake of therapeutics in a triple transgenic mouse model of Alzheimer's disease | Q43707054 | ||
Reduced CNS exposure of memantine in a triple transgenic mouse model of Alzheimer's disease assessed using a novel LC-MS technique | Q45355844 | ||
Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: An in situ cerebral perfusion study. | Q46011960 | ||
Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease | Q46651514 | ||
Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease | Q46702194 | ||
Low-temperature improved-throughput method for analysis of brain fatty acids and assessment of their post-mortem stability | Q46803631 | ||
Gender differences in the amount and deposition of amyloidbeta in APPswe and PS1 double transgenic mice | Q47316442 | ||
Fatty Acid-Binding Protein 5 at the Blood-Brain Barrier Regulates Endogenous Brain Docosahexaenoic Acid Levels and Cognitive Function. | Q47945490 | ||
Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions | Q48153919 | ||
The blood-brain barrier and protein-mediated fatty acid uptake: role of the blood-brain barrier as a metabolic barrier: An Editorial Comment for 'The blood-brain barrier fatty acid transport protein 1 (FATP1/SLC27A1) supplies docosahexaenoic acid to | Q48233444 | ||
Extension of a new two-trial memory task in the rat: influence of environmental context on recognition processes. | Q52043776 | ||
Fatty Acid-Binding Protein 5 Facilitates the Blood-Brain Barrier Transport of Docosahexaenoic Acid. | Q52148129 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | fatty acid | Q61476 |
blood–brain barrier | Q221694 | ||
P304 | page(s) | 81-92 | |
P577 | publication date | 2017-11-03 | |
P1433 | published in | Journal of Neurochemistry | Q6295643 |
P1476 | title | Reduced blood-brain barrier expression of fatty acid-binding protein 5 is associated with increased vulnerability of APP/PS1 mice to cognitive deficits from low omega-3 fatty acid diets | |
P478 | volume | 144 |
Q90567799 | Dietary Intake of Green Nut Oil or DHA Ameliorates DHA Distribution in the Brain of a Mouse Model of Dementia Accompanied by Memory Recovery | cites work | P2860 |